Introduction
Epilepsy is a common neurological disorder that affects approximately 50 million people worldwide. 1 Epilepsy and antiepileptic drugs (AEDs) therapy have deleterious effects on cognition in patients receiving them. A large number of the epileptic patients suffer from memory deficits, learning disabilities and behavioural problems. [6] [7] [8] Several factors viz.: biological (underlying neuropathology, seizure type and aetiology, age of onset, frequency, severity and duration of seizures, structural cerebral damage), psychological problems, treatment with AEDs and by surgery have been attributed to cause neurocognitive impairment. 2 It has been noticed that AEDs can also brings about untoward effect on cognition and behaviour. [3] [4] [5] It has been reported that the neurocognitive burden of epilepsy may even start before birth through in utero exposure to AEDs. [13] [14] [15] At therapeutic doses AED treatment disturbs memory formation, retention and orientation. These adverse effects were especially prominent in patients receiving polytherapy. [3] [4] [5] Among the established antiepileptic drugs barbiturates and benzodiazepines have demonstrated detrimental effects on cognition leading to decreased arousal and deficits in cognitive performance. 9, 10 Phenobarbital has more cognitive and behavioural toxicity as compared to carbamazepine, sodium valproate, clonazepam and phenytoin which cause mild cognitive impairment. 17 However, some of the newer antiepileptic drugs have been reported to have favourable cognitive and behavioural profile such as vigabatrine, gabapentin, levetiracetam, tiagabine. 17 Among the newer drugs topiramate administration to epileptic patients has brought about long term harmful effects on the cognitive functions and verbal fluency. [18] [19] [20] [21] It has been noticed that because of cognitive impairment the drug needs to be discontinued even when it is found to be improving seizure frequency. 18 However there are some clinical and preclinical reports available which suggest that topiramate treatment has no negative effect on cognitive functions. 22, 23 Although many researchers have suggested that lamotrigine is a safe drug [24] [25] [26] but there are certain indications which show that it might impair Seizure 20 (2011) 257-262 Cognitive impairment is frequently observed in epileptic patients. It has been seen that not only epilepsy but antiepileptic drugs also impair cognitive functions. The present study was undertaken to assess the effect of three anticonvulsants viz. memory. 16 Studies meant for assessing the effect of oxcarbazepine on cognitive functions in healthy human volunteers indicate a stimulant effect on memory and psychomotor functioning. 55 Oxcarbazepine treatment for over 6 months in children and adolescents with newly diagnosed partial seizures indicated that it does not affect cognition and intelligence as compared to carbamazepine and valproate. 56 Interestingly, a cross-sectional study indicated superiority of oxcarbazepine and lamotrigine compared to topiramate, valproic acid, carbamazepine and lithium in case of neurocognitive effects in patients suffering from mood disorders. 57 Thus it would be interesting to assess the comparative effects of three antiepileptic drugs viz. lamotrigine, oxcarbazepine and topiramate on cognitive functions. This comparison would further help in the decision to choose one drug over another. A number of experimental and clinical reports suggest the involvement of oxidative stress in pathophysiology of epilepsy. 27 The increased free radicals result in membrane lipid peroxidation and decreased glutathione concentrations in the epileptic focus. 28 Further, the involvement of free radicals in seizures is also supported by reports which indicate that exogenously administered antioxidant protects the brain against seizures. 29 Growing evidence
indicates that long term antiepileptic drug treatment leads to increase in oxidative stress which is similar to that observed during epileptogenesis. For example, valproic acid has been found to increase lipid peroxidation in patients receiving it. 30 Contrary to this observation some anti-epileptic agents like phenytoin have been shown to decrease oxidative stress demonstrated by increase in glutathione reductase activity in patients receiving it. 31 Prolonged oxidative damage to various brain sites have been suggested to be the more likely cause responsible for long term complications, morphological abnormalities and cognition impairment in neurodegenerative disorders. 11, 12 Further, increased free radicals lead to neuronal degeneration through increased lipid peroxidation, decreased glutathione levels and decrease in superoxide dismutase and catalase activites. 32 It is not clear whether antiepileptic drugs exert derangement of cognitive function through oxidative stress in spite of showing an antiepileptic effect. In perspective of the above citations, the present study was planned to assess the per se effect of newer antiepileptic drugs viz. lamotrigine, topiramate and oxcarbazepine on cognitive functions in kindled and non-kindled mice and to determine if oxidative stress was involved in the derangement of cognition.
Methods

Animals
Male albino Swiss strain mice weighing 25-30 g were procured from Central Animal House of University College of Medical Sciences (University of Delhi) and Guru Tegh Bahadur Hospital, Delhi, India. The animals were housed in propylene cages in groups of 6-8 mice per cage and kept under controlled environmental condition (temperature: 22 AE 2 8C), humidity: 50-55%, natural light/ day cycle). The mice received a standard pellet diet (Gold Mohar Lipton India Ltd., Kolkata) and water ad libitum. The animals were brought to the laboratory at least two hours before the experiments for acclimatization to the new premises. All the experiments were performed during the light phase between 9:00 AM and 4.00 PM. The work protocol was approved by Institutional Animal Ethics Committee and care of the animals was taken as per ''CPCSEA Guidelines for laboratory animal facilities''.
Drugs and dosing schedule
Lamotrigine and oxcarbazepine were gift sample from Sun Pharma, Ahmedabad. Topiramate (Topamax) tablets were purchased from market. Other (inactive) ingredients of Topamax are: lactose monohydrate, pregelatinized starch, micro crystalline cellulose, sodium starch glycolate, magnesium stearate, purified water, carnauba wax, hypromellose, titanium dioxide, polyethylene glycol, synthetic iron oxide and polysorbate 80. Lamotrigine, oxcarbazepine and topiramate tablets (after crushing) were dissolved in 1% CMC (carboxymethyl cellulose) solution. All Drugs were administered orally in a dose of 10 ml/kg. Pentylenetetrazole (Sigma Aldrich, USA) was dissolved in double distilled water and administered in a dose of 25 mg/kg, i.p. on every alternate day to induce kindling. Drug treatment was given till five weeks. The doses of drugs were standardized on the basis of the pilot studies conducted in the laboratory. Lamotrigine in dose of 5 mg/kg, p.o., oxcarbazepine in a dose of 15 mg/kg, p.o. and topiramate in a dose of 10 mg/kg, p.o. showed significant anticonvulsant effect in maximal electroshock seizure test (significant reduction of tonic extensor phase) and delayed PTZ-induced kindling in mice. 33 
Pentylenetetrazole induced kindling
For PTZ kindling, a subconvulsant dose of PTZ 25 mg/kg body weight was injected intraperitoneally on every second day (i.e. 
Cognition and behavioural tests
For the cognitive assessment each animal was assessed at a time. Cognition was assessed by following two separate behavioural tests.
Elevated plus maze
Elevated plus maze is widely used to assess the acquisition and retention latency of the animals. The maze was constituted of wood painted gray and contained a central platform (5 Â 5) cm with radiated four symmetrical arms: two open arms (16 Â 5) cm and two closed arms (16 Â 5 Â 10) cm with an open roof. The maze is elevated to a height of 25 cm from the floor. On the first day, the acquisition transfer latency was noted as follows: the mice were placed individually at the end of one open arm, facing away from central platform and the time it took to move from the open arm to either of the closed arm was recorded. During training, if the animal did not enter in closed arm within 90 s it was gently pushed in the closed arm. To become acquainted with the maze, the animals were allowed to explore the maze for 10 s after reaching the closed arm and then they returned to their home cage. The animals were retested 24 h after the first day training and the time taken to enter the closed arm was taken as retention latency. A time period of 90 s was taken as cut-off. 34 
Passive avoidance response
A derangement in memory was assessed by this test. Briefly, an inverted petridish was placed in the centre of the grid floor of a continuous avoidance apparatus. The petridish served as the shock free zone (SFZ). Mice were placed individually on SFZ and while on stepping down from the SFZ they were given an electric shock of 20 V through the grid floor. Animals were trained to remain on the SFZ for 60 s. The step-down latency in seconds was recorded after the last training session without giving shock, this was termed acquisition latency. The animals were retested after 24 h, without giving shock and the time taken for the mouse to step down was measured and termed as retention latency. A cut-off of 600 s was chosen for the animal which did not step down in this period. At the end of study period, the animals were sacrificed by ether anaesthesia; the brain was quickly dissected out in toto, washed with ice-cold sodium phosphate buffer, weighed and stored over ice. The brains were further processed within half an hour of dissection and the estimation of oxidative stress were done in the same working day. Brain tissue was homogenized with 10 times (w/v) sodium phosphate buffer. The homogenate was centrifuged at 3000 rpm for 15 min. The supernatant was used for the estimations of MDA, reduced glutathione levels, superoxide (SOD) and catalase activities.
Estimation of lipid peroxidation
Malondialdehyde (MDA), which is a measure of lipid peroxidation, was measured spectrophotometrically by the method described by Ohkawa et al. 36 
Estimation of reduced glutathione
Reduced glutathione was estimated spectrophotometrically by the method described by Ellman. 
Estimation of superoxide dismutase
Superoxide dismutase activity was determined by using the method proposed by Marklund and Marklund. 38 
Estimation of catalase
Catalase activity was determined by using the method proposed by Claiborne. 39 
Statistical analysis
The results are expressed as mean AE SEM (standard error of mean). Statistical analysis was performed using analysis of variance (ANOVA) with Tukey's post hoc statistical tests. A p < 0.05 was taken as the level of significance.
Results
Effect of different drug treatments alone on transfer latency (TL) in non-kindled mice
None of the administered drugs impaired cognition as evidenced by no significant change in acquisition and retention latencies in the elevated plus maze test (Fig. 1). 
Effect of different drug treatments on transfer latency (TL) in PTZkindled mice
There was no significant change observed in the TLs in various groups of animals during acquisition test. However, on the 2nd day vehicle treated PTZ-kindled group demonstrated significantly (p < 0.001) impaired retention TL as compared to control groups of animals. Further, topiramate (10 mg/kg) treatment was found to significantly impair the retention TL when compared to vehicle + PTZ-kindled group. However, lamotrigine and oxcarbazepine treatment did not impair the acquisition latency as well as retention latency when compared to vehicle + PTZ-kindled group (Fig. 2) .
Effect of different drug treatments alone on step down latency (SDL) in non-kindled mice
In all treatment groups no significant impairment was observed in acquisition and retention SDLs (Fig. 3) .
Effect of different drug treatments on step down latency (SDL) in PTZ-kindled mice
PTZ-kindling significantly impaired the cognition as evidenced by decreased SDL on the second day of the test. Neither lamotrigine nor oxcarbazepine impaired the cognition as indicated by no change in acquisition and retention SDLs in the PTZ-kindled animals. However, topiramate treatment was observed to produce a significant impairment of cognition as evidenced by a significantly decreased retention SDL (p < 0.001) (Fig. 4) .
Effect of different drug treatments alone on oxidative stress in whole brain tissue of non-kindled mice
In chronic study administration of lamotrigine and oxcarbazepine alone did not alter MDA and reduced glutathione levels, catalase and superoxide dismutase enzyme activities in whole brain tissues as compared to control group of animals. On the other hand, topiramate administration was found to increase the MDA levels as compared to control animals ( Table 1) . PTZ-kindled.
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Effect of various drugs on oxidative stress levels in kindled mice brain tissues
In PTZ-kindled mice MDA levels were observed to increase (p < 0.001) and reduced glutathione levels were found to decrease (p < 0.001) when compared to the values in control group of mice. Administration of oxcarbazepine and lamotrigine was also found to increase the MDA levels and decrease in reduced glutathione levels but results were not statistically different from those of vehicle treated PTZ-kindled animals. However, topiramate administration has further increased MDA levels (p < 0.001) and decreased glutathione levels (p < 0.01) as compared to the respective values in vehicle + PTZ kindled mice brain tissue (Table 1) .
Effect on mice brain SOD and catalase activity
No significant change in SOD and catalase activities was observed in all the treated groups when compared to control group (Table 1) .
Discussion
Clinical reports suggest that not only epilepsy but therapeutic drugs used in the treatment of epilepsy also exert negative effect on cognition which affects quality of life of epileptic patients. Many authors have reported efficacy of certain plants viz. Bacopa monnieri, 58 Embilica officinalis 59 and Centella asiatica 60 and active constituents viz. curcumin 61, 62 against epilepsy and oxidative stress. Some studies concluded the elevation of oxidative stress during epilepsy. Treatment with these plants and active constituents possessing antioxidant property has been shown to improve cognitive disorders in animals. Recently, an elevation of oxidative stress has been observed with the treatment of valproate, carbamazepine and levetiracetam in epileptic patients. 63 Reportedly, AED offers significant seizure suppression but impairs cognition and increases oxidative stress in patients. However, it is not clear whether it is epilepsy or oxidative stress or both which contribute to the decline of cognitive function. It has been reported consistently that older generation antiepileptic drugs cause cognitive impairment. 40 But, newer agents have been less explored for their adverse effect profile on cognition during epilepsy treatment. [17] [18] [19] [20] [21] [22] [23] [24] [25] The present study was conducted to compare the effects of three newer AED's viz. lamotrigine, oxcarbazepine and topiramate on cognition during experimental epileptogenesis in mice.
Step-down latency and transfer latency on passive avoidance apparatus and elevated plus tests, respectively were used to assess cognition. Experimental epilepsy was induced by repeated administration of pentylenetetrazole in mice.
The results of the present study indicate that (retention) transfer latency was significantly increased and (retention) stepdown latency was significantly decreased in vehicle treated PTZkindled mice as compared to control groups signifying memory impairment. However, acquisition latencies remained unaffected. Cognition tests were also performed in the third week but results showed no impairment (data not shown). Thus it is important to note that cognition impairment occurred only after the develop- ment of full kindling. Thus our results are in agreement with previous experimental data that has clearly depicted that PTZkindling impairs long term memory. 40 Our findings are also in agreement with the previous reports where kindling has induced retrograde amnesia in the shuttle box and step down avoidance test in rodents. 42 Clinical evidence available so far indicates that there is impairment of cognition in epileptic patients. [13] [14] [15] 41 Thus our results are in line with both preclinical data as well as clinical studies.
All the administered drugs viz., lamotrigine, oxcarbazepine and topiramate to non-kindled animals did not alter transfer latency as well as step-down latency in both acquisition as well as retention sessions thereby suggesting that these agents do not affect normal cognitive functions.
On contrary, topiramate administration to kindled animals showed significant increase in retention transfer and vice versa decrease in step down latency, suggesting impairment of cognition as compared to vehicle treated PTZ-kindled animals. These results indicate that not only kindling but its treatment with topiramate further culminates into cognitive impairment. Some previously documented studies support our results where topiramate administration in epileptic patients has impaired memory. 18, 19, 21, 22, 24 When lamotrigine and oxcarbazepine were administered to kindled animals, both groups showed no significant change in transfer and step-down latencies as compared to vehicle treated PTZ-kindled mice. These results suggest that cognition impairment in lamotrigine and oxcarbazepine treated animals could be due to epileptogenesis itself. While comparing these three drugs it was clear that lamotrigine and oxcarbazepine treatment do not cause cognitive impairment. These observations are further confirmed by the previous studies where lamotrigine and oxcarbazepine treatment showed no signs of neurobehavioural adverse effects on cognitive functions in the patients of epilepsy. 26, [43] [44] [45] [47] [48] [49] 51 Kindling effect is a relatively permanent alteration of brain functions leading to increased excitability to ineffective stimuli. Several reports indicate that free radical generation due to the increased activity of glutamatergic transmitter plays a crucial role in neuronal cell death of the PTZ-kindled animal. These free radicals cause cellular dysfunction by attacking the polyunsaturated sites of the biological membranes resulting into increased lipid peroxidation. The levels of glutathione are also reduced during oxidative stress. 29, 45, 46, 50, 53 Long term use of antiepileptic drugs have also been shown to increase oxidative stress. 54 On the background of these data, we have measured four oxidative stress parameters viz., malondialdehyde, glutathione levels, superoxide dismutase and catalase activities. Free radicals are normal products of cellular aerobic metabolism. However, when the production of free radicals increases or defence mechanism of the body decreases, they cause cellular dysfunction by attacking at the polyunsaturated sites of the biological membranes leading to lipid peroxidation. The increase in levels of MDA is a marker of lipid peroxidation. 29 Lamotrigine and oxcarbazepine administration to non-kindled animals showed no change in MDA level indicating that these drugs do not cause induction of oxidative stress. In contrast topiramate administration in non-kindled animals significantly increased MDA level indicating that topiramate induces oxidative stress.
In kindled animals the results show that MDA levels were increased in the vehicle treated PTZ-kindled brain tissues of mice. Lamotrigine and oxcarbazepine administration to kindled mice showed no significant change in oxidative stress markers as compared to vehicle treated PTZ-kindled group. However, topiramate treatment has further increased the oxidative stress in the PTZ-kindled mice. These results are in consistent with the previous studies which showed increased oxidative stress in the brain of kindled rodents. 29, 45 The accentuation of oxidative stress in topiramate treated kindled and non-kindled animals in our study is supported by in vitro experiments which demonstrated that topiramate increases oxidative stress in primary rat astrocytes. 51 Further, Cardile et al. 52 have also reported that topiramate has induced production of reactive oxygen species, increased nitric oxide synthesis, decreased glutamine synthetase activity and cell viability in primary cultures of rat cortical astrocytes. Thus, topiramate could be increasing oxidative stress in both kindled and non-kindled mice.
Glutathione is an endogenous antioxidant present mainly in the reduced form within the cells. It reacts with the free radicals and prevents the generation of hydroxyl radical, which is the most toxic form of free radicals. During this defensive process, reduced glutathione is converted to oxidized form with the help of the enzyme glutathione peroxidase. The biochemical results of the present study reveal comparable decrease in glutathione levels in vehicle-, lamotrigine-and oxcarbazepine-treated PTZ-kindled mice. The results show that this decline is due to kindling itself. However, topiramate treatment shows significant decrease in glutathione levels as compared to vehicle treated PTZ-kindled group. It is clear that glutathione was depleted while combating free radicals.
Superoxide dismutase (SOD) is an antioxidative enzyme of the brain. In the present study there was no change in SOD activities in all the treatment groups, this could be due to the fact that glutathione may be playing a crucial role in combating oxidative stress. Catalase is an enzyme responsible for detoxification of H 2 O 2 formed by the action of superoxide dismutase. The insignificant change in the activities of catalase might be due to the fact that the catalase activity in the rodent brain is very low 46, 51 and it may not be the key enzyme involved in intracellular antioxidant defence system in the brain. The present results further suggest that topiramate has more oxidative effect via MDA and glutathione than via superoxide dismutase or catalase activity. Thus the results of the present study suggest that lamotrigine and oxcarbazepine do not affect cognition during PTZ-induced kindling in mice while topiramate deteriorates cognitive functions by altering biochemical parameters during experimental epileptogenesis. It is also evident from the results that oxidative stress could be causative mechanism involved in cognitive impairment during experimental epileptogenesis as well as during drug treatment. Further, clinical and biochemical studies are required to demonstrate a correlation between cognitive dysfunction and oxidative stress during epilepsy and antiepileptic drug therapy.
